Found 5 matching trials
Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma PHASE1 This is a Phase Ib/II, open-label, single institution dose-escalation, safe...
Show More Location
University of Texas Health Science Center at San Antonio
Learn More & Join Trial
A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene PHASE1 The primary purpose of this study is to determine the safety and tolerabili...
Show More Location
Mount Sinai Comprehensive Cancer Center
Learn More & Join Trial
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) PHASE2 This is an open-label, multi-center, single arm, phase II study to assess t...
Show More Location
Dartmouth-Hitchcock Medical Center (DHMC)
Learn More & Join Trial
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC PHASE2 This is an open label, single arm, multi-centre phase II study to assess th...
Show More Location
City of Hope Cancer Center
Learn More & Join Trial
Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma PHASE2 MiST is a British Lung Foundation funded, University of Leicester Study, a ...
Show More Location
University Hospitals of Leicester NHS Trust
Learn More & Join Trial